Sign In
Buy CLX
$89.63
+1.10 (+1.24%)
At Close: Jun 04, 2026
Clorox (CLX) Lags Q2 Earnings Estimates
10:25pm, Thursday, 03'rd Feb 2022 Zacks Investment Research
Clorox (CLX) delivered earnings and revenue surprises of -15.38% and 0.75%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Clorox down 9% on narrowing sales, margins and bleaky outlook
10:20pm, Thursday, 03'rd Feb 2022 Seeking Alpha
Clorox (CLX) trades 8.5% down after hours on reporting a drop of 8% in FQ2 net sales to $1.7B compared to a 27% increase in the year-ago quarter, or an increase of 19% on a two-year
The Clorox Company (CLX) CEO Linda Rendle on Q2 2022 Results - Earnings Call Transcript
08:09pm, Thursday, 03'rd Feb 2022
The Clorox Company (CLX) CEO Linda Rendle on Q2 2022 Results - Earnings Call Transcript
Clorox (CLX) Lags Q2 Earnings Estimates
07:09pm, Thursday, 03'rd Feb 2022
Clorox (CLX) delivered earnings and revenue surprises of -15.38% and 0.75%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Clorox stock drops after company hit by lower margins, inflation
04:59pm, Thursday, 03'rd Feb 2022
Clorox Co. CLX, -0.99% shares fell nearly 9% in the extended session Thursday after the maker of cleaning and other products got hit by lower margins and fewer sales amid "challenging" costs and infla
Clorox Q2 2022 Earnings Preview
10:35pm, Wednesday, 02'nd Feb 2022 Seeking Alpha
Clorox (NYSE:CLX) is scheduled to announce Q2 earnings results on Thursday, February 3rd, after market close.The consensus EPS Estimate is $0.85 (-58.1% Y/Y) and the consensus
Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2022
03:05pm, Wednesday, 02'nd Feb 2022 Benzinga
Upgrades
Oppenheimer upgraded the previous rating for NovoCure Ltd (NASDAQ:NVCR) from Perform to Outperform. NovoCure earned $0.13 in the third quarter, compared to $0.09 in the year-ago quarter. At
Colgate-Palmolive wins out over Clorox in Bernstein''s household products check
01:55pm, Wednesday, 02'nd Feb 2022 Seeking Alpha
Bernstein now prefers Colgate-Palmolive (CL) over Clorox Company (CLX) in the household product sector based on its new ratings moves on Wednesday. Read more.
Meltdown Or Melt-Up? How To Handle The Volatility Of 2022 With An NPP Portfolio
02:00pm, Saturday, 29'th Jan 2022 Seeking Alpha
Is this bull market finally over? Or is the current slide just a bump in the road? We provide a stock investment strategy to capture maximal future gains, regardless of market direction.
Church & Dwight (CHD) Q4 Earnings and Revenues Top Estimates
01:15pm, Friday, 28'th Jan 2022 Zacks Investment Research
Church & Dwight (CHD) delivered earnings and revenue surprises of 10.34% and 1.47%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Clorox (CLX) Q2 Earnings Expected to Decline
08:02pm, Thursday, 27'th Jan 2022 Zacks Investment Research
Clorox (CLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Clorox (CLX) to Report Q2 Earnings: What's in the Offing?
04:48pm, Thursday, 27'th Jan 2022 Zacks Investment Research
Clorox (CLX) Q2 results are likely to reflect impacts of unfavorable price mix, lower shipments, and elevated logistics and commodity costs. Its IGNITE strategy and productivity initiatives bode well.
Clorox Q2 Earnings Preview: Can Price Increases Offset Inflationary Pressure?
03:30pm, Thursday, 27'th Jan 2022 The Motley Fool
Clorox is scheduled to report fiscal 2022 second-quarter earnings on Feb. 3.
Market Sell-Off 2022: 3 Ultra-Safe Dividend Stocks to Buy Now
03:00pm, Thursday, 27'th Jan 2022 The Motley Fool
This defensive basket is built to limit the effects of market volatility on your portfolio.
Clorox (CLX) to Report Q2 Earnings: What's in the Offing?
01:04pm, Thursday, 27'th Jan 2022
Clorox (CLX) Q2 results are likely to reflect impacts of unfavorable price mix, lower shipments, and elevated logistics and commodity costs. Its IGNITE strategy and productivity initiatives bode well.
